[60]Fullerene derivative modulates adenosine and metabotropic glutamate receptors gene expression: a possible protective effect against hypoxia

Antioxidants and human diseases

(2014) Peramaiyan Rajendran et al.   CLINICA CHIMICA ACTA

Modulation of Gene Expression of Adenosine and Metabotropic Glutamate Receptors in Rat's Neuronal Cells Exposed to L-Glutamate and [60]Fullerene

(2014) Davide Giust et al.   Journal of Biomedical Nanotechnology

Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes

(2012) Marco Matos et al.   GLIA

Modulation of Adenosine Receptors by [60]Fullerene Hydrosoluble Derivative in SK-N-MC Cells

(2011) Davide Giust et al.   ACS Chemical Neuroscience

Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration

(2010) Catarina V. Gomes et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Regulation of gene expression by hypoxia

(2008) Niall Steven Kenneth et al.   BIOCHEMICAL JOURNAL

RESEARCH ARTICLE: Up-regulation of Adenosine Receptors in the Frontal Cortex in Alzheimer's Disease

(2008) José L. Albasanz et al.   BRAIN PATHOLOGY

Modulation of adenosine A1 and A2A receptors in C6 glioma cells during hypoxia: involvement of endogenous adenosine

(2008) Carlos A. Castillo et al.   JOURNAL OF NEUROCHEMISTRY

Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation – Possible role as a dependence receptor

(2008) Sergey Pshenichkin et al.   NEUROPHARMACOLOGY

Adenosine A2A receptors in Parkinson’s disease treatment

(2008) Marek Cieślak et al.   Purinergic Signalling